Trademark: 97620822
Word
PHAGESELECT
Status
Pending
Status Code
630
Status Date
Saturday, October 8, 2022
Serial Number
97620822
Mark Type
3000
Filing Date
Wednesday, October 5, 2022

Trademark Owner History

Classifications
40 custom manufacture of bacteriophage therapeutics
9 computer software system for identifying precision therapy for treatment of bacterial infections
5 human, animal, plant and microorganism biological preparations for use in drug development, disease modeling and personalized medicine to prevent or treat bacterial infectious diseases; bactericides, namely, biological preparations to treat bacterial infections and bacterial contamination in the fields of medicine, farming, and food preparation; bactericides, namely, biological preparations to treat bacterial contamination in the industrial and food preparation fields; diagnostic kits comprised of medical diagnostic reagents for testing bacteria sensitivity
1 diagnostic reagents for clinical and medical laboratory use; diagnostic kits comprising reagents for testing bacteria sensitivity
44 medical testing for diagnostic or treatment purposes in the field of personalized medicine; health care services, namely, providing a database in the field of personalized medicine and featuring inputting and collection of data and information all for treatment and diagnostic purposes; clinical and medical laboratory testing services for diagnostic purposes in the fields of disease diagnostics and personalized medicine; providing medical diagnostic assays and diagnostic and prognostic testing for treatment purposes of bacteria infections and the analysis, evaluation, and reporting of those test results to help healthcare professionals determine a patient's clinical diagnosis, the effectiveness of patient treatments, and to revise future treatments accordingly; medical services; consulting services in the field of medical diagnostic and prognostic testing; medical analysis services for diagnostic and prognostic testing and treatment purposes; providing medical diagnostic and prognostic testing services; medical analysis services relating to the diagnosis and treatment of a person; microbiological laboratory testing of bacteria for diagnostic and medical purposes, and technical consultation thereto; medical testing and diagnostic services for diagnostic or treatment purposes, in particular performing tests using diagnostic assays
42 research and development in the fields of personalized medicine and diagnostics; data mining of healthcare and genetic information in the field of precision medicine and personalized medicine; scientific study and research in the fields of biochemistry, disease, personalized medicine, personalized therapeutics, and/or pharmaceuticals; clinical and medical laboratory testing services for medical research purposes in the fields of disease diagnostics and personalized medicine; pharmaceutical drug research and development; custom assay development; pharmaceutical drug discovery and development services; providing laboratory research services in the field of medical diagnostics and personalized medicine; medical research services; biotechnology research; providing medical and scientific research information in the field of clinical trials; research and development of vaccines and therapeutics; non-downloadable computer software application in the field of personalized medicine to provide medical and diagnostic services involving bacterial infections; providing medical diagnostic assays and diagnostic and prognostic testing for medical research purposes of bacterial infections and the analysis, evaluation and reporting of those test results to help healthcare professionals for research purposes; development of new technology for others in the field of biotechnology; laboratory research in the field of genomic sequencing; research and development in the pharmaceutical and biotechnology fields; research development, engineering and testing services in the fields of bacteria and viruses; laboratory research in the field of infectious diseases; medical and scientific research in the field of immunotherapy; medical laboratory services; microbiological laboratory testing of bacteria for research purposes and technical consultation thereto; scientific and medical research, in particular, design and development of diagnostic assays
The mark consists of the word PHAGESELECT to the right of a hexagon design made up of seven individual hexagons and lines connecting all but one of the seven hexagons.
PHAGE SELECT
Color is not claimed as a feature of the mark.

Trademark Events
Oct 26, 2022
Notice Of Design Search Code E-Mailed
Oct 25, 2022
New Application Office Supplied Data Entered In Tram
Oct 8, 2022
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24